Difference in epidemiology and antibiotic susceptibility of methicillin resistant and methicillin susceptible Staphylococcus aureus isolates

Saderi, Horieh; Owlia, Parviz; Nadoushan, Mohammad Reza Jalali
October 2009
Iranian Journal of Clinical Infectious Diseases;Fall2009, Vol. 4 Issue 4, p219
Academic Journal
Background: Antimicrobial resistance of Staphylococcus aureus especially methicillin resistant S. aureus (MRSA) continues to be a problem for clinicians worldwide. Although difference in epidemiology and antibiotic susceptibility of methicillin resistant S. aureus (MRSA) and methicillin susceptible S. aureus (MSSA) isolates has been proposed by investigators, few data have been reported to now. Patients and methods: Disk diffusion method was used for determination of in vitro susceptibility of S. aureus isolates to 15 antibiotics. Susceptibility pattern of 192 non-duplicates S. aureus isolated from clinical specimens in four university hospitals in Tehran, from November 2007 to August 2008, were compared. In addition, distribution of MRSA and MSSA isolates were investigated in different specimens, on various wards, and in different age groups. Results: MRSA isolates were constituted 49% of all isolates. While only 1.7% of the MSSA isolates were multidrug resistant, all of MRSA were shown resistance to at least five antibiotics. Majority of isolates from patients ≥65 years old were MRSA and prevalence of methicillin resistance was highest among S. aureus isolated from respiratory specimens. Also, MRSA appeared to be more prevalent in intensive care units and operation wards than in other departments. Conclusion: This study has shown a relationship between methicillin resistance and resistance to other antibiotics in S. aureus isolates. Also, considerable differences were observed in epidemiology of MRSA and MSSA isolates.


Related Articles

  • Cleaning Up the Farm. BLACK, JANE // Prevention;Mar2014, Vol. 66 Issue 3, p102 

    The article discusses the worsening antibiotic resistance in the U.S. as 2 million people in the U.S. get infections resistant to antibiotics every years with at least 23,000 people dying as a result. It points out that dozens of new, virulent bacteria have emerged over the years including...

  • Detection of inducible clindamycin resistance (MLSBi) among methicillin-resistant Staphylococcus aureus (MRSA) from Libya. Ahmed, Mohamed O.; Alghazali, Mohamed H.; Abuzweda, Abdelalbaset R.; Amri, Samira G. // Libyan Journal of Medicine;Mar2010, Vol. 5 Issue 5, p1 

    The article presents a study which examines methicillin-resistant Staphylococcus aureus (MRSA) collected isolates to detect inducible clindamycin resistance (MLSBi) in Libya. The study found 128 MRSA isolates as Staphylococcus aureus and researchers tested them against erythromycin, clindamycin...

  • Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA). Duplessis, Christopher; Crum-Cianflone, Nancy F. // Clinical Medicine Reviews in Therapeutics;2011, Vol. 3, p1 

    Microbial resistance has reached alarming levels, threatening to outpace the ability to counter with more potent antimicrobial agents. In particular, methicillin-resistant Staphylococcus aureus (MRSA) has become a leading cause of skin and soft-tissue infections and PVL-positive strains have...

  • Synthesis and minimum inhibitory concentrations of SK-03-92 against Staphylococcus aureus and other gram-positive bacteria. Schwan, William; Kabir, M.; Kallaus, Maren; Krueger, Sarah; Monte, Aaron; Cook, James // Journal of Infection & Chemotherapy (Springer Science & Business;Feb2012, Vol. 18 Issue 1, p124 

    Staphylococcus aureus causes hundreds of thousands of infections and thousands of deaths per year in the United States. The emergence of methicillin-resistant S. aureus (MRSA), including community-associated methicillin-resistant S. aureus (CA-MRSA), has added to the problem. As MRSA continue to...

  • In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus. Zhang, Yong; Teng, Da; Wang, Xiumin; Mao, Ruoyu; Cao, Xintao; Hu, Xiaoyuan; Zong, Lifen; Wang, Jianhua // Applied Microbiology & Biotechnology;Aug2015, Vol. 99 Issue 15, p6255 

    Currently, more antimicrobial drug candidates are urgently needed to combat the rise in drug-resistance among pathogenic microbes. A new antimicrobial peptide, MP1102, a variant of NZ2114, was designed, evaluated, and overexpressed in Pichia pastoris. The total secreted protein in cultures...

  • Cfr-Mediated Linezolid-Resistance among Methicillin-Resistant Coagulase-Negative Staphylococci from Infections of Humans. Cui, Lanqing; Wang, Yang; Li, Yun; He, Tao; Schwarz, Stefan; Ding, Yujing; Shen, Jianzhong; Lv, Yuan // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Four methicillin-resistant coagulase-negative staphylococci (MRCoNS), one Staphylococcus haemolyticus and three Staphylococcus cohnii, from infections of humans collected via the Ministry of Health National Antimicrobial Resistance Surveillance Net (Mohnarin) program in China were identified as...

  • Could new antibiotic have MRSA in its sights?  // Pharmaceutical Technology Europe;Jul2006, Vol. 18 Issue 7, p10 

    The article reports that researchers have developed platensimycin which could be used against methicillin-resistant Staphylococcus aureus. The drug is produced by Streptomyces platensis and is the most potent inhibitor of the FabF enzyme. FabF is utilized in fatty acid formation if bacterial...

  • Antibiotic Resistance Patterns and Plasmid Profiles of Methicillin Resistant Staphylococcus aureus Isolates from Human Samples. Ibe, Chibuike; Onyeagba, Reginald Azu; Ugochukwu, Solomon Charles // British Microbiology Research Journal;2014, Vol. 4 Issue 2, p185 

    Antibiograms and plasmid profiles are commonly used to characterizemethicillin-resistant Staphylococcus aureus (MRSA) inepidemiologic studies. However, antibiograms are frequently inadequate to accomplish the differentiation. Plasmid profile being more informative has been reported to be useful...

  • ANTIOXIDANT NATURE OF ALLICIN TO CURE METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS. Hena, J. Vimalin; Ngangom, Ronibala // International Journal of Pharma & Bio Sciences;Jan-Mar2011, Vol. 2 Issue 1, pB529 

    Methicillin resistant Staphylococcus aureus (MRSA) continues to be one of the commonest pathogen encountered in clinical as well as laboratory practice. It has become a major health problem world wide. Newer antimicrobials/agents are urgently needed to combat this problem of MRSA resistance to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics